The use of remifentanil during general anesthesia for caesarean sectionVan de Velde, MarcCurrent Opinion in Anesthesiology: June 2016 - Volume 29 - Issue 3 - p 257–260 doi: 10.1097/ACO.0000000000000334 OBSTETRICS AND GYNECOLOGICAL ANESTHESIA: Edited by Marc Van de Velde Buy Abstract Author InformationAuthors Article MetricsMetrics Purpose of review The purpose is to review the neonatal and maternal effects of remifentanil given at induction of general anesthesia for caesarean section and prior to delivery of the baby. Main findings Remifentanil seems to have short-lived respiratory depressant effects in approximately 50% of neonates, requiring short periods of mask ventilation or tactile stimulation of the neonate. Remifentanil produces excellent maternal hemodynamic stability avoiding tachycardia and hypertension, possibly reducing the risk of maternal awareness. Summary Remifentanil can be safely used at induction of general anesthesia provided healthcare workers are available to manage short-lived neonatal depression. Department of Cardiovascular Sciences, Department of Anesthesiology, UZ Leuven, KU Leuven, Leuven, Belgium Correspondence to Marc Van de Velde, MD, PhD, EDRA, Professor of Anesthesiology, Department of Cardiovascular Sciences, Section Anaesthesiology, Catholic University Leuven, University Hospitals Leuven, Herestraat 49, B-3000 Leuven, Belgium. Tel: +0032 16 34 42 70; fax: +0032-16 34 42 45; e-mail: firstname.lastname@example.org Copyright © 2016 YEAR Wolters Kluwer Health, Inc. All rights reserved.